A systematic review and meta‐analysis of pharmacist‐led fee‐for‐services medication review
- 20 December 2013
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 77 (1), 102-115
- https://doi.org/10.1111/bcp.12140
Abstract
AimThe aim was to examine the impact of fee-for-service pharmacist-led medication review on patient outcomes and quantify this according to the type of review undertaken, e.g. adherence support and clinical medication review. MethodsRelevant published studies were identified from Medline, Embase and International Pharmaceutical Abstract databases (from inception to February 2011). Study inclusion criteria were fee-for-service medication review, presence of a control group and pre-specified patient outcomes. Outcomes were grouped into primary (changes in biomarkers, hospitalization, and mortality) and secondary outcomes (medication adherence, economic implications and quality of life). Meta-analyses for primary outcomes were conducted using random effects models and secondary outcomes were summarized using descriptive statistics. ResultsOf the 135 relevant articles located, 21 studies met the inclusion criteria for primary outcomes and 32 for secondary outcomes. Significant results favouring pharmacists' intervention were found for blood pressure (OR 3.50, 95% CI 1.58, 7.75, P = 0.002) and low density lipoprotein (OR 2.35, 95% CI 1.17, 4.72, P = 0.02). Outcomes on hospitalization (OR 0.69, 95% CI 0.39, 1.21, P = 0.19) and mortality (OR 1.50, 95% CI 0.65 to 3.46, P = 0.34) indicated no differences between the groups. On subgroup analysis, clinical medication review (OR 0.46, 95% CI 0.26, 0.83, P = 0.01) but not adherence support review (OR 0.88, 95% CI 0.59, 1.32, P = 0.54) reduced hospitalization. ConclusionsThe majority of the studies (57.9%) showed improvement in medication adherence. Fee-for-service pharmacist-led medication reviews showed positive benefits on patient outcomes. Interventions that include a clinical review had a significant impact on patient outcomes by attainment of target clinical biomarkers and reduced hospitalization.Keywords
This publication has 46 references indexed in Scilit:
- A cluster randomized controlled Trial to Evaluate an Ambulatory primary care Management program for patients with dyslipidemia: the TEAM studyCMAJ : Canadian Medical Association Journal, 2010
- The Effectiveness of Collaborative Medicine Reviews in Delaying Time to Next Hospitalization for Patients With Heart Failure in the Practice SettingCirculation: Heart Failure, 2009
- Does pharmacist‐led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta‐analysisBritish Journal of Clinical Pharmacology, 2007
- Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the communityThorax, 2007
- Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trialBMJ, 2007
- Home-based medication review in a high risk elderly population in primary care--the POLYMED randomised controlled trialAge and Ageing, 2007
- Costs of a Community Pharmacist-Led Medicines Management Service for Patients with Coronary Heart Disease in EnglandPharmacoEconomics, 2007
- Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once‐daily atorvastatinPharmacoepidemiology and Drug Safety, 2005
- Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled studyJournal of Cardiac Failure, 2003
- Pharmaceutical Care Services for Asthma Patients: A Controlled Intervention StudyThe Journal of Clinical Pharmacology, 2001